These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9656982)

  • 1. Fatality resulting from intraventricular vincristine administration.
    Meggs WJ; Hoffman RS
    J Toxicol Clin Toxicol; 1998; 36(3):243-6. PubMed ID: 9656982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accidental intraventricular vincristine administration: an avoidable iatrogenic death.
    Lau G
    Med Sci Law; 1996 Jul; 36(3):263-5. PubMed ID: 8918096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal vincristine: fatal myeloencephalopathy despite cerebrospinal fluid perfusion.
    Alcaraz A; Rey C; Concha A; Medina A
    J Toxicol Clin Toxicol; 2002; 40(5):557-61. PubMed ID: 12215050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inadvertent intrathecal vincristine administration: report of a fatal case despite cerebrospinal fluid lavage and a review of the literature.
    Pongudom S; Chinthammitr Y
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S258-63. PubMed ID: 21721457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal vincristine: an analysis of reasons for recurrent fatal chemotherapeutic error with recommendations for prevention.
    Fernandez CV; Esau R; Hamilton D; Fitzsimmons B; Pritchard S
    J Pediatr Hematol Oncol; 1998; 20(6):587-90. PubMed ID: 9856687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing vincristine administration errors: Does evidence support minibag infusions?
    Schulmeister L
    Clin J Oncol Nurs; 2006 Apr; 10(2):271-3. PubMed ID: 16708708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid lavage in the treatment of inadvertent intrathecal vincristine injection.
    Al Ferayan A; Russell NA; Al Wohaibi M; Awada A; Scherman B
    Childs Nerv Syst; 1999 Mar; 15(2-3):87-9. PubMed ID: 10230662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inadvertent intrathecal vincristine administration: a neurosurgical emergency. Case report.
    Qweider M; Gilsbach JM; Rohde V
    J Neurosurg Spine; 2007 Mar; 6(3):280-3. PubMed ID: 17355029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Fatal Cases of Accidental Intrathecal Vincristine Administration: Learning from Death Events.
    Chotsampancharoen T; Sripornsawan P; Wongchanchailert M
    Chemotherapy; 2016; 61(2):108-10. PubMed ID: 26636546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.
    Ferreri AJ; Reni M; Dell'Oro S; Ciceri F; Bernardi M; Camba L; Ponzoni M; Terreni MR; Tomirotti M; Spina M; Villa E
    Oncology; 2001; 60(2):134-40. PubMed ID: 11244328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
    Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inadvertent intramuscular administration of vincristine: lack of untoward effects without any treatment except administration of hot compresses.
    Olcay L; Safak T
    Pediatr Hematol Oncol; 2003; 20(5):427-8. PubMed ID: 12775543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged survival following the inadvertent intrathecal administration of vincristine: clinical and electrophysiologic analyses.
    Bleck TP; Jacobsen J
    Clin Neuropharmacol; 1991 Oct; 14(5):457-62. PubMed ID: 1742755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma.
    Moser AM; Adamson PC; Gillespie AJ; Poplack DG; Balis FM
    Cancer; 1999 Jan; 85(2):511-6. PubMed ID: 10023723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inadvertent intrathecal injection of daunorubicin with fatal outcome.
    Mortensen ME; Cecalupo AJ; Lo WD; Egorin MJ; Batley R
    Med Pediatr Oncol; 1992; 20(3):249-53. PubMed ID: 1574039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural toxicity induced by accidental intrathecal vincristine administration.
    Kwack EK; Kim DJ; Park TI; Cho KR; Kwon IH; Sohn YK
    J Korean Med Sci; 1999 Dec; 14(6):688-92. PubMed ID: 10642952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
    Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J;
    J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accidental intramuscular vincristine: lack of untoward effects and recommendations for management.
    Clark BS; Gallegos E; Bleyer WA
    Med Pediatr Oncol; 1997 Apr; 28(4):314-5. PubMed ID: 9078327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal myeloencephalopathy due to accidental intrathecal vincristin administration: a report of two cases.
    Dettmeyer R; Driever F; Becker A; Wiestler OD; Madea B
    Forensic Sci Int; 2001 Oct; 122(1):60-4. PubMed ID: 11587867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term intensive treatment (V.A.A.P.) of adult acute lymphoblastic leukemia and lymphoblastic lymphoma.
    Willemze R; Peters WG; Colly LP
    Eur J Haematol; 1988 Nov; 41(5):489-95. PubMed ID: 3208871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.